Kristal Taylor

University of Texas Health Science Center at Houston, Houston, Texas, United States

Are you Kristal Taylor?

Claim your profile

Publications (2)7.01 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To establish the risk of unidentified neoplasia and subsequent adverse outcomes in patients undergoing laparoscopic supracervical hysterectomy (SCH) with morcellation. Methods This was a retrospective review of all consecutive women who had undergone laparoscopic SCH at a single institution between January 2002 and December 2008. We abstracted charts for patient characteristics and outcomes. Results We identified 808 women with planned laparoscopic SCH with morcellation. The median age was 44.1 years (range, 23.4-79.8 years). The most common indications were menorrhagia (n=472 patients, 58.4%) and leiomyomata (n=400 patients, 49.5%). Of the 30 patients converted to an open procedure prior to morcellation, one had leiomyosarcoma on final pathology. Of the 778 patients who completed laparoscopic SCH with morcellation, 16 (2.0%) patients had endometrial hyperplasia and 3 (0.4%) patients had cancer on final pathology. Abnormal pathology appeared more likely in women over 50 years of age with abnormal bleeding. Of the 778 patients, 189 were under 40 years of age, and 4 (2.1%) of these 189 women had hyperplasia on final pathology; none had cancer. Of the 433 patients age 40-49 years, 8 (1.8%) patients had hyperplasia or cancer. Of the 156 patients age 50 years or older, 7 (4.5%) had hyperplasia (P=.18); none had cancer. No patient with hyperplasia or morcellated cancer had adverse sequelae after a median follow-up of 90.4 months. Conclusion In this cohort of patients who underwent laparoscopic SCH, the risk of hyperplasia or malignancy was low. Laparoscopic SCH with morcellation appears to be a low risk procedure.
    Journal of Minimally Invasive Gynecology 09/2014; 22(2). DOI:10.1016/j.jmig.2014.09.005 · 1.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare intraoperative and postoperative outcomes, pathologic findings, cancer recurrence, and death rates in normal-weight, overweight, obese, and morbidly obese women undergoing radical hysterectomy and pelvic lymphadenectomy for early-stage cervical cancer. A review of patients who underwent radical hysterectomy and pelvic lymphadenectomy for invasive cervical cancer between 1990 and 2006 was performed. On the basis of body mass index (BMI) (calculated as weight [kg]/[height (m)](2)), women were categorized as normal weight (BMI 18.5-24.9), overweight (BMI 25.0-29.9), obese (BMI 30.0-34.9), or morbidly obese (BMI at least 35.0). Four hundred eight women met the inclusion criteria. Of these, 155 (38%) were normal weight, 126 (31%) were overweight, 77 (19%) were obese, and 50 (12%) were morbidly obese. There were no statistically significant differences between these four groups in age, Charlson comorbidity score, smoking history, stage, histologic grade or subtype, tumor size, depth of invasion, transfusion rate, operative time, or intraoperative complications. Higher BMI was significantly correlated with higher estimated operative blood loss (P=.001). There were no statistically significant differences between the groups in pathologic findings, length of postoperative hospital stay, postoperative complications, readmission rate, or proportion of women receiving adjuvant radiotherapy. At a median follow-up time of 64 months, there were no differences between groups in rates of recurrence or death from disease. Radical hysterectomy and pelvic lymphadenectomy is feasible for obese and morbidly obese women with cervical cancer. Obesity alone should not be a contraindication to radical hysterectomy in women with cervical cancer.
    Obstetrics and Gynecology 11/2008; 112(4):899-905. DOI:10.1097/AOG.0b013e3181863280 · 5.18 Impact Factor